Clorox Co (NYSE:CLX) Shares Purchased by Slow Capital Inc.

Slow Capital Inc. increased its stake in shares of Clorox Co (NYSE:CLX) by 2.4% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 5,196 shares of the company’s stock after acquiring an additional 120 shares during the period. Slow Capital Inc.’s holdings in Clorox were worth $795,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its stake in Clorox by 8.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 582,745 shares of the company’s stock valued at $89,822,000 after acquiring an additional 45,408 shares during the period. Geode Capital Management LLC lifted its stake in Clorox by 21.5% during the 4th quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after acquiring an additional 335,835 shares during the period. Two Sigma Advisers LP acquired a new stake in Clorox during the 4th quarter valued at approximately $355,000. Millennium Management LLC lifted its stake in Clorox by 323.7% during the 4th quarter. Millennium Management LLC now owns 6,643 shares of the company’s stock valued at $1,024,000 after acquiring an additional 9,613 shares during the period. Finally, Truvestments Capital LLC acquired a new stake in Clorox during the 1st quarter valued at approximately $41,000. 77.01% of the stock is currently owned by hedge funds and other institutional investors.

In other Clorox news, SVP Diego J. Barral sold 1,987 shares of the company’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $157.59, for a total transaction of $313,131.33. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Denise Garner sold 20,399 shares of the company’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $157.61, for a total transaction of $3,215,086.39. Following the transaction, the senior vice president now owns 4,896 shares of the company’s stock, valued at $771,658.56. The disclosure for this sale can be found here. Insiders have sold 25,786 shares of company stock valued at $4,054,776 over the last 90 days. 1.40% of the stock is currently owned by company insiders.

CLX has been the subject of several analyst reports. UBS Group boosted their target price on shares of Clorox from $110.00 to $128.00 and gave the company a “sell” rating in a research note on Friday, August 2nd. BMO Capital Markets set a $168.00 target price on shares of Clorox and gave the company a “buy” rating in a research note on Thursday, May 2nd. Royal Bank of Canada boosted their target price on shares of Clorox to $161.00 and gave the company a “sector perform” rating in a research note on Friday, August 2nd. Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 target price for the company in a research note on Monday, July 29th. Finally, Argus cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Monday, May 20th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $154.07.

NYSE:CLX traded up $0.64 during trading hours on Tuesday, reaching $159.22. 36,792 shares of the company were exchanged, compared to its average volume of 1,100,633. The company has a debt-to-equity ratio of 4.09, a quick ratio of 0.55 and a current ratio of 0.91. The stock has a 50-day moving average of $158.29. The firm has a market cap of $20.20 billion, a price-to-earnings ratio of 25.23, a PEG ratio of 4.98 and a beta of 0.37. Clorox Co has a twelve month low of $139.26 and a twelve month high of $167.70.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.84 by $0.04. The company had revenue of $1.63 billion during the quarter, compared to analysts’ expectations of $1.69 billion. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The firm’s revenue for the quarter was down 3.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.66 earnings per share. As a group, research analysts anticipate that Clorox Co will post 6.4 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 16th. Shareholders of record on Wednesday, July 31st will be given a dividend of $1.06 per share. The ex-dividend date of this dividend is Tuesday, July 30th. This is a boost from Clorox’s previous quarterly dividend of $0.96. This represents a $4.24 dividend on an annualized basis and a yield of 2.66%. Clorox’s dividend payout ratio is currently 67.09%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: Is the QQQ ETF safe?

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.